AngioDynamics Inc (ANGO) stock
ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/306% below fair value
$12.42+0.35 (+2.90%)
Close on Nov 11, 2026Market cap $522.32MP/E –Yield –
AngioDynamics operating margin
Operating margin is operating income as a percentage of revenue.
AngioDynamics's operating margin for the twelve months ending Aug 31, 2026 was -11.2%. For fiscal 2026 it was -12.5%, against -13.7% the year before. The highest annual figure on record is 9.7% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | May 31, 2026 | -12.5% | +1.2 |
| FY2025 | May 31, 2025 | -13.7% | +49.7 |
| FY2024 | May 31, 2024 | -63.3% | −48.2 |
| FY2023 | May 31, 2023 | -15.1% | −6.1 |
| FY2022 | May 31, 2022 | -9.0% | +3.1 |
| FY2021 | May 31, 2021 | -12.1% | +51.1 |
| FY2020 | May 31, 2020 | -63.3% | −59.8 |
| FY2019 | May 31, 2019 | -3.5% | +1.9 |
| FY2018 | May 31, 2018 | -5.4% | −1.3 |
| FY2017 | May 31, 2017 | -4.1% | −4.4 |
| FY2016 | May 31, 2016 | 0.3% | +1.3 |
| FY2015 | May 31, 2015 | -1.0% | −3.9 |
| FY2014 | May 31, 2014 | 3.0% | +1.4 |
| FY2013 | May 31, 2013 | 1.5% | +3.9 |
| FY2012 | May 31, 2012 | -2.4% | −7.9 |
| FY2011 | May 31, 2011 | 5.5% | −4.1 |
| FY2010 | May 31, 2010 | 9.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -9.0% | +5.1 |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -11.8% | −4.6 |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -16.5% | −2.7 |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -7.7% | +7.5 |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -14.1% | +5.3 |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -7.2% | +13.1 |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -13.9% | +252.0 |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -15.2% | +1.4 |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -19.4% | −63.9 |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -20.4% | +2.5 |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -265.9% | −254.8 |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -16.6% | −7.1 |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | 44.5% | +60.8 |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -22.9% | −15.5 |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -11.1% | −3.9 |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -9.5% | +1.6 |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -16.3% | −5.8 |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -7.4% | +20.7 |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -7.2% | −1.9 |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -11.1% | −4.4 |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -10.5% | −3.2 |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -28.1% | +240.4 |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -5.3% | +3.7 |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | -6.6% | −1.8 |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -7.3% | −6.0 |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -268.5% | −272.6 |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -8.9% | −3.3 |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -4.9% | −1.3 |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -1.3% | +8.3 |
| Q4 FY2019CQ2 2019 | May 31, 2019 | 4.1% | +34.8 |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | -5.6% | −13.2 |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -3.6% | −5.3 |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -9.6% | −9.8 |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -30.7% | +10.2 |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | 7.6% | +1.6 |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | 1.7% | −15.8 |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | 0.2% | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -40.8% | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | 6.0% | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | 17.5% | – |
See a number that looks wrong?